1-3 of 3
Maciej Paszkowski-Rogacz
Close
Sort by
Journal Articles

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug

Martin Wermke, Aylin Camgoz, Maciej Paszkowski-Rogacz, Sebastian Thieme, Malte von Bonin, Andreas Dahl, Uwe Platzbecker, Mirko Theis, Gerhard Ehninger, Sebastian Brenner, Martin Bornhäuser, Frank Buchholz
Journal: Blood
Blood (2015) 125 (24): 3760–3768.
https://doi.org/10.1182/blood-2014-07-590646
Published: 2015
Includes: Supplemental data
Journal Articles

A Genome Wide shRNA Screen In Primary Human AML Cells Identifies ROCK1 As a Novel Therapeutic Target

Martin Wermke, MD, Aylin Camgoz, Maciej Paszkowski-Rogacz, PhD, Sebastian Thieme, PhD, Malte von Bonin, MD, Andreas Dahl, PhD, Mirko Theis, PhD, Gerhard Ehninger, MD, Sebastian Brenner, MD, Martin Bornhäuser, MD, Frank Buchholz, PhD
Journal: Blood
Blood (2013) 122 (21): 170.
https://doi.org/10.1182/blood.V122.21.170.170
Published: 2013
Journal Articles

Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells

Katharina Ross, Anna K. Sedello, Gabriele Putz Todd, Maciej Paszkowski-Rogacz, Alexander W. Bird, Li Ding, Tatyana Grinenko, Kira Behrens, Nina Hubner, Matthias Mann, Claudia Waskow, Carol Stocking, Frank Buchholz
Journal: Blood
Blood (2012) 119 (18): 4152–4161.
https://doi.org/10.1182/blood-2011-09-382390
Published: 2012
Includes: Supplemental data